Rhumbline Advisers Inmune Bio, Inc. Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
A detailed history of Rhumbline Advisers transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 22,336 shares of INMB stock, worth $44,448. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,336
Previous 19,153
16.62%
Holding current value
$44,448
Previous $149,000
65.77%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding INMB
# of Institutions
98Shares Held
6.31MCall Options Held
1.63MPut Options Held
3.34M-
Vanguard Group Inc Valley Forge, PA848KShares$1.69 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$1.62 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$1.19 Million45.87% of portfolio
-
Ubs Group Ag449KShares$893,9490.0% of portfolio
-
Geode Capital Management, LLC Boston, MA390KShares$775,9620.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $35.7M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...